Stephen Mayo - Insider Trading & Ownership

Entity
Individual
Location
2000 Galloping Hill Rd, Kenilworth, NJ
Summary
The estimated net worth of Stephen Mayo is at least $3.92M dollars as of June 7, 2024. Stephen Mayo is the Director of Allogene Therapeutics, Inc. and owns shares of Allogene Therapeutics, Inc. (ALLO) stock worth about $1.92M. Stephen Mayo is the Director of Merck & Co., Inc. and owns shares of Merck & Co., Inc. (MRK) stock worth about $1.19M. Stephen Mayo is the Director of Sarepta Therapeutics, Inc. and owns shares of Sarepta Therapeutics, Inc. (SRPT) stock worth about $814K.
All Insider Reports
All Insider Reports

Ownership of Stephen Mayo

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ALLO Allogene Therapeutics, Inc. Director $1.92M Jun 5, 2024
MRK Merck & Co., Inc. Director $1.19M May 31, 2024
SRPT Sarepta Therapeutics, Inc. Director $814K -$385K -32.1% Mar 5, 2024

Insider Transactions Reported by Stephen Mayo:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.